Ophthalmology Glaucoma

Scope & Guideline

Empowering Clinicians with Cutting-Edge Insights

Introduction

Explore the comprehensive scope of Ophthalmology Glaucoma through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Ophthalmology Glaucoma in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN2589-4234
PublisherELSEVIER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2018 to 2024
AbbreviationOPHTHALMOL GLAUCOMA / Ophthalmol. Glaucoma
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Ophthalmology Glaucoma' serves as a prominent platform for advancing knowledge in the field of glaucoma, focusing on both clinical and experimental research to improve patient outcomes.
  1. Clinical Research and Treatment Outcomes:
    The journal emphasizes studies that evaluate clinical practices, treatment efficacy, and surgical outcomes in glaucoma management, including comparisons of various surgical techniques and medications.
  2. Innovative Diagnostic Techniques:
    There is a strong focus on the development and validation of new diagnostic tools and imaging technologies, such as OCT and AI applications, to enhance the understanding of glaucoma progression and management.
  3. Epidemiological Studies and Risk Factors:
    Research addressing the epidemiology of glaucoma, including risk factors and demographic studies, helps to understand the disease's impact across different populations.
  4. Patient-Centered Research:
    The journal publishes studies related to patient-reported outcomes, quality of life, and adherence to treatment, highlighting the importance of patient perspectives in glaucoma care.
  5. Technological Advances in Glaucoma Management:
    Papers exploring the role of technology in glaucoma monitoring and treatment, including telemedicine and digital health solutions, are a key component of the journal's scope.
The journal has identified several emerging themes that reflect current trends and advancements in glaucoma research, showcasing the evolving landscape of the field.
  1. Telemedicine and Remote Monitoring:
    As seen from recent publications, there is a growing trend towards telehealth solutions for glaucoma management, driven by the need for accessible care and monitoring, particularly highlighted during the COVID-19 pandemic.
  2. Artificial Intelligence and Machine Learning:
    The integration of AI in glaucoma diagnosis and management is on the rise, with studies exploring its potential for improving diagnostic accuracy and predicting disease progression.
  3. Minimally Invasive Glaucoma Surgery (MIGS):
    MIGS techniques are increasingly featured, reflecting a trend towards less invasive procedures that aim to reduce complications and recovery times for patients.
  4. Patient Engagement and Education:
    Research focusing on enhancing patient knowledge and adherence through educational interventions and digital resources is emerging as a significant theme, emphasizing the role of informed patients in effective glaucoma management.
  5. Socioeconomic and Racial Disparities in Glaucoma Care:
    An increasing number of studies address the impact of social determinants of health on glaucoma diagnosis and treatment, highlighting the need for equitable healthcare solutions.

Declining or Waning

While the journal covers a broad range of topics, certain areas of focus have seen a decline in prominence over recent years, reflecting shifts in research interests and advancements in technology.
  1. Traditional Surgical Techniques:
    There appears to be a decreasing emphasis on traditional surgical methods as newer, less invasive techniques gain popularity, indicating a shift towards minimally invasive glaucoma surgeries.
  2. Pharmacological Treatments:
    Research centered around older pharmacological treatments for glaucoma is becoming less frequent, as newer agents and combination therapies are explored, suggesting a transition in focus towards innovative therapeutic options.
  3. General Reviews and Meta-Analyses:
    The frequency of general review articles and meta-analyses has diminished, possibly due to a growing preference for original research that offers new insights and data.
  4. Basic Science and Mechanistic Studies:
    Although still relevant, there is a noticeable decline in publications focusing solely on the basic science of glaucoma pathophysiology, as applied research and clinical applications take precedence.

Similar Journals

Clinical and Experimental Gastroenterology

Advancing gastrointestinal health through innovative research.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7023Frequency: 1 issue/year

Clinical and Experimental Gastroenterology is a prestigious Open Access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of gastroenterology through rigorous research and innovative insights. With its ISSN 1178-7023, the journal has established a significant presence since its inception in 2008 and has been actively contributing to the academic landscape from New Zealand. The journal has attained a commendable Q2 rank in the Gastroenterology category as of 2023, placing it in the upper-tier percentile of similar journals. It currently ranks #57 out of 167 in the Scopus database, highlighting its relevance and impact in the field at the 66th percentile. Encompassing a wide range of topics within gastroenterology, the journal aims to foster discussion and disseminate findings that enhance clinical practices and patient care. Researchers, healthcare professionals, and students alike will find this journal an invaluable resource for cutting-edge research and developments in gastrointestinal health.

Ophthalmology and Therapy

Empowering Professionals with Cutting-Edge Insights
Publisher: SPRINGER INT PUBL AGISSN: 2193-8245Frequency: 2 issues/year

Ophthalmology and Therapy is a premier open-access journal published by Springer International Publishing AG, dedicated to advancing the field of ophthalmology through innovative research and clinical studies. With an ISSN of 2193-8245 and an E-ISSN of 2193-6528, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in eye care and vision science. The journal has achieved a remarkable impact factor and has been recognized as a Q1 journal in Ophthalmology, reflecting its contributions to the discipline and its high-quality publications. Operating from the United Kingdom, Ophthalmology and Therapy is an open-access platform that has been available since 2012, ensuring that critical research is accessible to a global audience. Its commitment to fostering collaboration and knowledge sharing is exemplified by its ranking of #39 out of 137 in the Scopus category for Medicine – Ophthalmology, placing it in the 71st percentile of its peers. Together, these attributes highlight the journal's importance as a key forum for the dissemination of cutting-edge research, making it an essential addition to the libraries of institutions and professionals engaged in ophthalmic care.

JOURNAL OF CLINICAL PERIODONTOLOGY

Shaping the Future of Oral Health Research
Publisher: WILEYISSN: 0303-6979Frequency: 12 issues/year

JOURNAL OF CLINICAL PERIODONTOLOGY, published by Wiley, is a leading academic journal dedicated to advancing the understanding and practice of periodontology. Since its inception in 1974, the journal has carved a niche in the field, achieving a remarkable Q1 ranking in Periodontics and securing a commendable Scopus rank of #2 out of 24 in Dentistry, placing it within the 93rd percentile of its category. With a robust commitment to publishing rigorous research, clinical studies, and comprehensive reviews, the journal provides an essential platform for researchers, dental professionals, and students to disseminate knowledge and keep abreast of the latest advancements in periodontal science. Although the journal is not open access, it remains highly influential in shaping the practices that underpin effective patient care and improving oral health globally. The journal's address in Hoboken, New Jersey, belies its international reach and the diverse contributions it attracts from around the world, ensuring its relevance and prestige in the rapidly evolving landscape of clinical periodontology.

Spektrum der Augenheilkunde

Navigating the Spectrum of Eye Health
Publisher: SPRINGER WIENISSN: 0930-4282Frequency: 6 issues/year

Welcome to Spektrum der Augenheilkunde, a distinguished journal published by SPRINGER WIEN, dedicated to the field of ophthalmology since its inception in 1987. With an ISSN of 0930-4282 and an E-ISSN of 1613-7523, this journal is recognized for its commitment to publishing original research, reviews, and clinical studies that address current and emerging topics in eye health and treatment. Although classified in the Q4 category for ophthalmology as per the latest 2023 rankings, it serves as a valuable platform for researchers, professionals, and students looking to contribute to and expand their knowledge in this vital area of medicine. Based in Austria and accessible through various academic databases, the journal aims to foster communication among professionals and advance the understanding of ocular diseases, innovative therapies, and clinical best practices.

JAMA Ophthalmology

Catalyzing Change in the Field of Ophthalmology
Publisher: AMER MEDICAL ASSOCISSN: 2168-6165Frequency: 12 issues/year

JAMA Ophthalmology, the premier journal in the field of ophthalmology, is published by the esteemed American Medical Association. Renowned for its rigorous peer-review process and commitment to advancing eye health research, JAMA Ophthalmology holds a prestigious position in the scientific community, boasting an impressive impact factor and ranking as Q1 in the category of Ophthalmology. With a Scopus rank of #3 out of 137 in its field and a remarkable 98th percentile, the journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to the ophthalmic sciences. Readers can explore a wealth of cutting-edge findings, clinical studies, and review articles that not only contribute to the sustainable advancement of ophthalmic knowledge but also foster innovative approaches in patient care. As we converge into 2024, the journal continues to embrace open access principles, ensuring that groundbreaking research is readily available to a global audience, enhancing collaborative efforts and furthering the development of the ophthalmology discipline.

Prostate Cancer

Advancing prostate cancer research for a healthier tomorrow.
Publisher: HINDAWI LTDISSN: 2090-3111Frequency: 1 issue/year

Prostate Cancer is a leading peer-reviewed Open Access journal published by HINDAWI LTD, dedicated to advancing the field of urology and oncology through high-quality research and innovative studies. Established in 2011, this journal serves as a vital platform for disseminating findings related to prostate cancer diagnostics, treatment strategies, and patient care, striving to collaborate and connect researchers from around the globe. With an impact factor reflective of its critical input in the scientific community, the journal showcases compelling manuscripts, reviews, and case reports that are accessible to a wide audience given its open access policy. Located in London, England, Prostate Cancer has made significant strides in its category quartiles, achieving Q4 in Cancer Research and Q3 in both Oncology and Urology as of 2023, reflecting its growing relevance and readership. With Scopus rankings indicating its position within the broader medical fields, the journal is a valuable resource for researchers, professionals, and students alike, contributing to the collective effort to improve outcomes in prostate cancer research and treatment.

Journal of Translational Internal Medicine

Innovating Internal Medicine for a Healthier Tomorrow
Publisher: SCIENDOISSN: 2450-131XFrequency: 4 issues/year

The Journal of Translational Internal Medicine is a renowned platform dedicated to advancing the field of internal medicine through the dissemination of high-quality research and innovative clinical practices. Published by SCIENDO, this journal boasts a respectable Q2 ranking in the Internal Medicine category and is placed in the 69th percentile among its peers, highlighting its significant contribution to the discipline. With its ISSN 2450-131X and E-ISSN 2224-4018, the journal offers an open-access format, promoting accessibility to vital research findings for professionals and scholars around the globe. Located in Poland, the journal has been a valuable resource since its inception in 2018, and it continues to thrive through 2024 and beyond, supporting the objective of translating research into practice, enhancing patient care, and fostering collaboration among researchers and healthcare providers. This makes it an essential read for anyone invested in improving medical outcomes and understanding the evolving challenges faced in internal medicine.

BMJ Open Ophthalmology

Exploring Breakthroughs in Eye Health and Treatment
Publisher: BMJ PUBLISHING GROUPISSN: 2397-3269Frequency: 1 issue/year

BMJ Open Ophthalmology is an esteemed, open-access journal dedicated to the field of ophthalmology, published by the renowned BMJ Publishing Group. Established in 2016, this journal has quickly made its mark within the ophthalmology community, achieving a respectable Q2 ranking in the 2023 category quartiles. It is indexed in Scopus, boasting a commendable ranking of **#52** out of **137** in the medicine discipline of ophthalmology, placing it in the **62nd percentile**. This global platform is committed to disseminating high-quality research, clinical studies, and innovative practices that propel the understanding and treatment of eye diseases. With its open access model, BMJ Open Ophthalmology ensures that vital research is readily available to health professionals, researchers, and students, fostering collaboration and advancing knowledge within the field. The journal is based in London, United Kingdom, and continues to welcome submissions that explore the latest advancements in ophthalmic science, contributing to enhanced patient care and outcomes.

Journal of Current Ophthalmology

Bridging Research and Practice: Enhancing Eye Health Together
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2452-2325Frequency: 4 issues/year

Journal of Current Ophthalmology is a premier scholarly platform dedicated to advancing the field of ophthalmology, published by Wolters Kluwer Medknow Publications. Established as an Open Access journal since 2015, it aims to provide unrestricted access to high-quality research that fosters knowledge sharing and collaboration among researchers, practitioners, and students in the field. The journal covers a broad spectrum of topics within ophthalmology, from clinical practices to groundbreaking research, contributing significantly to the medical community's understanding of eye health and diseases. With an impact factor reflecting its significance, it ranks in the Q2 category of ophthalmology and stands at #66 out of 137 in Scopus rankings, placing it in the 52nd percentile of its field as of 2023. The Journal of Current Ophthalmology is committed to publishing cutting-edge findings and innovative solutions, establishing itself as an essential resource for all professionals engaged in ocular research and care.

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE

Pioneering Research for Visionary Care.
Publisher: GEORG THIEME VERLAG KGISSN: 0023-2165Frequency: 12 issues/year

Klinische Monatshefte für Augenheilkunde is a distinguished peer-reviewed journal published by Georg Thieme Verlag KG, dedicated to advancing knowledge in the field of ophthalmology and general medicine. With an ISSN of 0023-2165 and an E-ISSN of 1439-3999, this journal has been a reputable platform for researchers and clinicians since its inception in 1963, continuing its impactful contributions through to 2024. Recognized in the Q3 quartile for both Medicine (miscellaneous) and Ophthalmology, this journal serves as a vital resource for those involved in ocular health, offering insights into clinical practices, recent advancements, and essential research findings. Despite its traditional publishing model, the journal retains a significant role in the academic community, as evidenced by its current Scopus ranking of #90/137 in the field of Ophthalmology. It is an essential read for professionals and students aiming to stay at the forefront of ophthalmic research and clinical innovations.